Table 2.

Association between high AIP and the risk of HPR according to the presentation of AMI.

	Non-AMI (n = 7599)		AMI (n = 3136)
	OR (95% CI)	P	OR (95% CI)	P
Model 1	0.85 (0.77–0.94)	0.002	0.90 (0.77–1.05)	0.180
Model 2	0.89 (0.80–0.99)	0.030	0.99 (0.83–1.18)	0.918
Model 3	0.89 (0.79–0.99)	0.028	1.00 (0.84–1.19)	0.986

AIP atherogenic index of plasma; AMI acute myocardial infarction; BMI body mass index; CI confidence interval; CTO chronic total occlusion; HPR high platelet reactivity; OR odds ratio.

Model 1: unadjusted.

Model 2: adjusted for age ≥ 75 years, sex, hypertension, diabetes, dyslipidemia, obesity, smoking, and chronic kidney disease.

Model 3: Model 2 + adjusted for medical therapy, including beta-blockers, angiotensin blockers, calcium channel blockers, and statins.